Schonfeld Strategic Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,580
Closed -$1.85M 2194
2025
Q1
$1.85M Buy
5,580
+55
+1% +$18.2K 0.01% 896
2024
Q4
$1.7M Sell
5,525
-40,569
-88% -$12.5M 0.01% 841
2024
Q3
$9.78M Buy
46,094
+21,634
+88% +$4.59M 0.07% 247
2024
Q2
$6.85M Buy
+24,460
New +$6.85M 0.04% 411
2024
Q1
Sell
-12,458
Closed -$2.88M 2061
2023
Q4
$2.88M Sell
12,458
-59,077
-83% -$13.7M 0.02% 627
2023
Q3
$10.4M Buy
71,535
+51,670
+260% +$7.55M 0.08% 301
2023
Q2
$4.59M Sell
19,865
-9,939
-33% -$2.3M 0.04% 512
2023
Q1
$7.22M Buy
29,804
+15,204
+104% +$3.68M 0.07% 354
2022
Q4
$4.24M Sell
14,600
-54,136
-79% -$15.7M 0.04% 529
2022
Q3
$4.47M Buy
68,736
+56,389
+457% +$3.66M 0.04% 564
2022
Q2
$884K Buy
+12,347
New +$884K 0.01% 1007
2022
Q1
Sell
-8,905
Closed -$754K 2575
2021
Q4
$754K Buy
8,905
+3,105
+54% +$263K 0.01% 1001
2021
Q3
$463K Sell
5,800
-400
-6% -$31.9K ﹤0.01% 1234
2021
Q2
$604K Sell
6,200
-24,254
-80% -$2.36M 0.01% 1064
2021
Q1
$3.56M Buy
+30,454
New +$3.56M 0.04% 495
2020
Q4
Sell
-6,507
Closed -$773K 1697
2020
Q3
$773K Sell
6,507
-1,378
-17% -$164K 0.01% 740
2020
Q2
$893K Sell
7,885
-36
-0.5% -$4.08K 0.02% 586
2020
Q1
$529K Buy
+7,921
New +$529K 0.03% 561
2019
Q2
Sell
-2,700
Closed -$338K 1143
2019
Q1
$338K Sell
2,700
-28,200
-91% -$3.53M 0.01% 803
2018
Q4
$3.48M Sell
30,900
-29,000
-48% -$3.27M 0.13% 216
2018
Q3
$12.8M Buy
59,900
+54,000
+915% +$11.6M 0.57% 26
2018
Q2
$1.65M Buy
5,900
+2,108
+56% +$590K 0.09% 304
2018
Q1
$443K Buy
+3,792
New +$443K 0.03% 500